Author Interviews, Cancer Research, Cost of Health Care, JAMA / 18.01.2020
Medicaid Expansion Linked to Improved Access for Head and Neck Cancer Patients
MedicalResearch.com Interview with:
Evan M. Graboyes, MD
Surveillance and Health Services Research
American Cancer Society, Atlanta, Georgia
Department of Otolaryngology–Head & Neck Surgery
Medical University of South Carolina, Charleston
MedicalResearch.com: What is the background for this study?
Response: Prior studies have shown that Medication Expansions under the Patient Protection and Affordable Care Act (ACA) are associated with a decrease in uninsured individuals and increases in the percentage of nonelderly patients diagnosed with localized (stage I-II) cancer, primarily for cancers for which effective screening tests exist.
Because no screening test exists for head and neck squamous cell carcinoma (HNSCC), access to care for physical examination and tissue-based biopsy- and thus health insurance coverage- are critical for the timely recognition of symptoms, early disease stage at diagnosis, and treatment initiation.
However, the downstream association of changes in health insurance coverage following Medicaid expansion under the ACA with stage at diagnosis and time to treatment initiation, key metrics for access to care for HNSCC, remain unknown.
(more…)